Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02622256 · ClinicalTrials.gov registry record · NA
Twitter and CV Health
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 611
- Enrollment target
NCT02622256: Completed NA study, sponsored by University of Pennsylvania.
NCT02622256 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 611 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02622256, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 611 participants
- Enrollment target
Study Summary
Cardiovascular (CV) disease is associated with significant morbidity and mortality. In the current digital age, needed is a better understanding of how information on social media sites may inform our approaches to improving CV health through novel methodologies. Investigators propose to study the conversation on Twitter about several CV diseases and their associated sequelae.
Interventions
- BEHAVIORAL Health System: HTN Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 611 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02622256
The ClinicalTrials.gov registry entry for NCT02622256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 611 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Health System: HTN Intervention is the first listed.
NCT02622256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02622256 about?
NCT02622256 is a clinical study titled "Twitter and CV Health". Cardiovascular (CV) disease is associated with significant morbidity and mortality. In the current digital age, needed is a better understanding of how information on social media sites may inform our approaches to improving CV health through novel methodologies. Investigators propose to study the c...
What is the current status of trial NCT02622256?
This trial is currently completed. It is a NA study. The enrollment target is 611 participants. The study started on 2016-06. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02622256?
The interventions under investigation include: Health System: HTN Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02622256?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.